Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 16622993 | HLA-CLASS I (HLA CLASS II) | hematopoietic stem cell transplantations | Thai | methotrexate | NA | unclassified | |
| the authors evaluated the outcome of ten children given hematopoietic stem cell transplantations from thai unrelated donors (urd-hsct) selected using dna high-resolution typing of both hla class i and ii loci. | |||||||
| 21418834 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematopoietic stem cell transplantations | NA | dexamethasone | NA | unclassified | |
| the patient was then followed by human leukocyte antigen 10/10 allele identical non-consanguinity allogeneic hematopoietic stem cell transplantations (allo-hsct) and soon the successful implantation of donor hematopoietic cells and persistent recovery was achieved. | |||||||
| 25360136 | HLA (HLA) | hematopoietic stem cell transplantations | European | NA | NA | unclassified | |
| the degree of hla concordance with the patient has long been known to be the major donor-related prediction factor for the success of hematopoietic stem cell transplantations and, with the progress of hla typing technology, selection criteria became more stringent with regard to the recommended loci and resolution. | |||||||
| 26131415 | HLA (HLA) | hematopoietic stem cell transplantations | Korean | NA | NA | unclassified | |
| these data can be used to resolve ambiguous results of hla typing for organ and hematopoietic stem cell transplantations. | |||||||
| 30129271 | HLA (HLA) | hematopoietic stem cell transplantations | NA | NA | NA | negation | |
| the xr kits did not resolve all the cwd hla allele ambiguities, which may be important for organ and/or hematopoietic stem cell transplantations. | |||||||
| 34303650 | HLA MATCHED (HLA-MATCHED) | hematopoietic stem cell transplantations | NA | NA | NA | unclassified | |
| all hematopoietic stem cell transplantations (hscts) were human leukocyte antigen-matched (hla-matched) and the majority used familial donors (77%). | |||||||
| 15231282 | HLA-DQA1*01 | corpse | NA | NA | NA | only_studied | |
| we describe here the relationships among detection rates achieved by four dna typing systems (d1s80 typing, th01 typing, hla dqa1 typing, and pm typings), the post-mortem interval, types of specimens (bone, nail, and blood), post-mortem changes, and the site at which the corpse was found (indoors, outdoor, or in the sea). | |||||||
| 31160572 | HLA-E (HLA-E) | melanocytic nevi | NA | NA | NA | positive | |
| consistently, hla-e expression is increased on senescent cells in human skin sections from old individuals, when compared with those from young, and in human melanocytic nevi relative to normal skin. | |||||||
| 15256773 | HLA (HLA) | lymphocytic hypophysitis | NA | NA | NA | negation | |
| the hla types frequently detected in lymphocytic hypophysitis were recognized, supporting the view that the cphd in this case may be caused by lymphocytic hypophysitis, although magnetic resonance imaging of the pituitary gland showed no specific findings. | |||||||
| 15316370 | HLA-DR (HLA-DR) | aspartylglucosaminuria | NA | NA | NA | unclassified | |
| two siblings with aspartylglucosaminuria underwent allogeneic bone marrow transplants using unrelated human leukocyte antigen-a, -b, and dr identical donors at ages 10 years 5 months and 5 years 10 months, respectively. | |||||||
Copyright 2024